Market Closed -
Saudi Arabian S.E.
05:50:02 27/06/2024 pm IST
|
5-day change
|
1st Jan Change
|
46.5
SAR
|
+0.11%
|
|
-0.96%
|
-21.72%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,525
|
3,468
|
4,836
|
6,416
|
9,504
|
7,440
|
-
|
-
|
Enterprise Value (EV)
1 |
3,045
|
3,717
|
4,932
|
6,588
|
9,571
|
7,712
|
7,818
|
7,839
|
P/E ratio
|
27.3
x
|
26.5
x
|
53.7
x
|
24.9
x
|
31.3
x
|
23.7
x
|
21.9
x
|
19.4
x
|
Yield
|
-
|
1.73%
|
1.49%
|
3.62%
|
2.36%
|
2.92%
|
3.26%
|
3.73%
|
Capitalization / Revenue
|
2.59
x
|
3.5
x
|
5.08
x
|
5.72
x
|
8.08
x
|
6.01
x
|
5.48
x
|
4.74
x
|
EV / Revenue
|
3.13
x
|
3.75
x
|
5.18
x
|
5.87
x
|
8.13
x
|
6.23
x
|
5.76
x
|
4.99
x
|
EV / EBITDA
|
13.1
x
|
13.1
x
|
19.7
x
|
16.8
x
|
21.4
x
|
19.1
x
|
16.4
x
|
14.7
x
|
EV / FCF
|
22.1
x
|
12.4
x
|
11.7
x
|
27.8
x
|
32.2
x
|
39.5
x
|
84.4
x
|
27.5
x
|
FCF Yield
|
4.54%
|
8.04%
|
8.52%
|
3.59%
|
3.11%
|
2.53%
|
1.19%
|
3.64%
|
Price to Book
|
1.61
x
|
2.04
x
|
2.91
x
|
3.75
x
|
5.15
x
|
3.86
x
|
3.7
x
|
3.52
x
|
Nbr of stocks (in thousands)
|
1,60,000
|
1,60,000
|
1,60,000
|
1,60,000
|
1,60,000
|
1,60,000
|
-
|
-
|
Reference price
2 |
15.78
|
21.68
|
30.22
|
40.10
|
59.40
|
46.50
|
46.50
|
46.50
|
Announcement Date
|
10/03/20
|
28/03/21
|
24/03/22
|
12/03/23
|
18/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
974.1
|
991.8
|
951.9
|
1,122
|
1,177
|
1,237
|
1,357
|
1,571
|
EBITDA
1 |
232
|
284.8
|
250.3
|
392.2
|
446.9
|
404.7
|
475.8
|
532.1
|
EBIT
1 |
129.6
|
180.9
|
131.2
|
291.8
|
342.6
|
321.1
|
363.6
|
407.8
|
Operating Margin
|
13.3%
|
18.24%
|
13.79%
|
26%
|
29.11%
|
25.96%
|
26.8%
|
25.96%
|
Earnings before Tax (EBT)
1 |
109.5
|
150.7
|
117.6
|
274.2
|
321
|
352.7
|
365.2
|
413
|
Net income
1 |
93
|
130.8
|
90.09
|
257.3
|
303.3
|
332.7
|
344.7
|
390.2
|
Net margin
|
9.55%
|
13.19%
|
9.46%
|
22.93%
|
25.78%
|
26.9%
|
25.41%
|
24.84%
|
EPS
2 |
0.5775
|
0.8175
|
0.5625
|
1.610
|
1.900
|
1.965
|
2.121
|
2.400
|
Free Cash Flow
1 |
138.1
|
298.8
|
420
|
236.6
|
297.5
|
195
|
92.67
|
285
|
FCF margin
|
14.18%
|
30.13%
|
44.13%
|
21.08%
|
25.28%
|
15.76%
|
6.83%
|
18.14%
|
FCF Conversion (EBITDA)
|
59.53%
|
104.94%
|
167.78%
|
60.32%
|
66.57%
|
48.18%
|
19.47%
|
53.56%
|
FCF Conversion (Net income)
|
148.5%
|
228.4%
|
466.24%
|
91.94%
|
98.08%
|
58.61%
|
26.88%
|
73.03%
|
Dividend per Share
2 |
-
|
0.3750
|
0.4500
|
1.450
|
1.400
|
1.358
|
1.517
|
1.736
|
Announcement Date
|
10/03/20
|
28/03/21
|
24/03/22
|
12/03/23
|
18/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
1 |
282.4
|
250.9
|
281.9
|
246.9
|
342.6
|
298.6
|
276.7
|
297.8
|
303.7
|
277
|
EBITDA
|
-
|
90.99
|
99.13
|
-
|
-
|
-
|
118.8
|
-
|
98.69
|
-
|
EBIT
1 |
16.97
|
70.1
|
70.1
|
62.11
|
81.62
|
91.76
|
93.7
|
86.6
|
-
|
-74.9
|
Operating Margin
|
6.01%
|
27.94%
|
24.86%
|
25.15%
|
23.82%
|
30.73%
|
33.86%
|
29.08%
|
-
|
-27.04%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
10.67
|
-
|
65.1
|
57.11
|
73.17
|
81.42
|
81.8
|
74.9
|
65.19
|
64.04
|
Net margin
|
3.78%
|
-
|
23.09%
|
23.13%
|
21.35%
|
27.27%
|
29.56%
|
25.15%
|
21.47%
|
23.12%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
0.5100
|
0.5100
|
0.4700
|
0.4100
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
24/03/22
|
26/05/22
|
24/08/22
|
03/11/22
|
12/03/23
|
15/05/23
|
10/08/23
|
06/11/23
|
18/03/24
|
19/05/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
520
|
249
|
96.3
|
172
|
67.3
|
272
|
378
|
399
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.243
x
|
0.8749
x
|
0.3848
x
|
0.4373
x
|
0.1506
x
|
0.6709
x
|
0.7941
x
|
0.7498
x
|
Free Cash Flow
1 |
138
|
299
|
420
|
237
|
298
|
195
|
92.7
|
285
|
ROE (net income / shareholders' equity)
|
6.11%
|
8.01%
|
5.37%
|
15.3%
|
16.9%
|
15.9%
|
17.3%
|
18.9%
|
ROA (Net income/ Total Assets)
|
3.7%
|
5.26%
|
3.84%
|
10.8%
|
12%
|
12.5%
|
12.1%
|
12.5%
|
Assets
1 |
2,511
|
2,486
|
2,348
|
2,372
|
2,538
|
2,662
|
2,849
|
3,127
|
Book Value Per Share
2 |
13.10
|
14.20
|
10.40
|
10.70
|
11.50
|
12.10
|
12.60
|
13.20
|
Cash Flow per Share
2 |
2.520
|
3.630
|
3.050
|
3.050
|
2.200
|
2.260
|
2.370
|
2.590
|
Capex
1 |
45.1
|
18.6
|
14.6
|
16.7
|
53.5
|
154
|
253
|
161
|
Capex / Sales
|
4.63%
|
1.88%
|
1.53%
|
1.49%
|
4.55%
|
12.45%
|
18.63%
|
10.27%
|
Announcement Date
|
10/03/20
|
28/03/21
|
24/03/22
|
12/03/23
|
18/03/24
|
-
|
-
|
-
|
Last Close Price
46.5
SAR Average target price
57.69
SAR Spread / Average Target +24.06% Consensus |
1st Jan change
|
Capi.
|
---|
| -21.72% | 198.31Cr | | -34.77% | 1.32TCr | | +4.48% | 1.18TCr | | -3.60% | 1.16TCr | | +8.44% | 1.07TCr | | +28.58% | 863.85Cr | | -9.79% | 724.36Cr | | +10.23% | 698.42Cr | | +8.41% | 646.11Cr | | 0.00% | 499.07Cr |
Hospitals, Clinics & Primary Care Services
|